MODIFIZIERTE L-NUKLEINSÄURE

European patent · EP1438321 · Deleted

Register entry

Publication number
EP1438321
Application number
EP02783007
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Oct 25, 2002
Published
Jul 21, 2004
Granted
May 26, 2010
Deleted
May 28, 2022
Reason
Annual fee unpaid
IPC classes
C07H 21/00 (2006.01)
G01N 33/53 (2006.01)
C12Q 1/68 (2006.01)
A61K 31/7088 (2006.01)
Priority
EP 01125630 26.10.2001
EP 02017300 01.08.2002
PCT application
PCT/EP2002/011950 25.10.2002
PCT publication
WO2003/035665 01.05.2003
Filing language
German
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 28, 2022

    Deleted, fee unpaid

    Published in Swissreg on 28.05.2022

  2. Sep 23, 2021

    Inventor

    Inventor
    LANGE, Christian, Brehmstrasse 65, 10439 Berlin, Germany, ESCHGFÄLLER, Bernd, Hohenstaufenstrasse 67, 10781 Berlin, Germany, KLUSSMANN, Sven, Paulsborner Strasse 83, 10709 Berlin, Germany → LANGE, Christian, Schulzestrasse 20, 13187 Berlin, Germany, ESCHGFÄLLER, Bernd, Hohenlohestr. 15, 90491 Nürnberg, Germany, KLUSSMANN, Sven, Paulsborner Strasse 83, 10709 Berlin, Germany

    Published in Swissreg on 23.09.2021

  3. Aug 28, 2010

    Agent entered

    Representative
    Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich

    Published in Swissreg on 28.08.2010

  4. May 26, 2010

    Granted

    Published in Swissreg on 26.05.2010

Parties

Holder

Noxxon Pharma AG

Max-Dohrn-Strasse 8-10, 10589 Berlin, DE

Agent

Isler & Pedrazzini AG

Postfach 1772, 8027 Zürich

Inventor

LANGE, Christian

13187 Berlin, DE

ESCHGFÄLLER, Bernd

90491 Nürnberg, DE

KLUSSMANN, Sven

10709 Berlin, DE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.